|After two years of implementation, we are now |
getting a chance to evaluate the Medical Device Innovation
Protection Act's impact on the medical device industry.
Executive Vice President, MasterControl Inc.
Since January 2013, medical device manufacturers and importers have been paying a 2.3 percent excise tax as part of the Affordable Care Act. The tax is assessed regardless of the company’s profitability.
Critics say the excise tax stifles innovations and kills jobs, while supporters say it will be offset by the increased number of insured people receiving treatments.